Description

Send us a text

This episode focuses on the FDA's approval of Journavx, a new class of pain medication that offers an alternative to traditional narcotics like OxyContin. Listeners learn about the significance of clinical trials, patient involvement, and the evolution of pain management strategies while emphasizing the need for informed discussions with healthcare providers. 
• Introduction to Jernovex and its pain management potential 
• Importance of clinical trials in drug development 
• Discussion on the practical implications for patients 
• Shift in medical policy around narcotic use 
• Overview of phase four trials and their significance 
• Resources offered by MedEvidence for reliable health information 
• Call to action for patients to engage with their healthcare providers regarding new treatment options

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.com

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!